Authors: Casey, DE Zorn, SH

Citation: De. Casey et Sh. Zorn, The pharmacology of weight gain with antipsychotics, J CLIN PSY, 62, 2001, pp. 4-10

Authors: Mansbach, RS Carver, J Zorn, SH

Citation: Rs. Mansbach et al., Blockade of drug-induced deficits in prepulse inhibition of acoustic startle by ziprasidone, PHARM BIO B, 69(3-4), 2001, pp. 535-542

Authors: Schmidt, AW Lebel, LA Howard, HR Zorn, SH

Citation: Aw. Schmidt et al., Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile, EUR J PHARM, 425(3), 2001, pp. 197-201

Authors: Rollema, H Lu, Y Schmidt, AW Sprouse, JS Zorn, SH

Citation: H. Rollema et al., 5-HT1A receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex, BIOL PSYCHI, 48(3), 2000, pp. 229-237

Authors: Sprouse, JS Reynolds, LS Braselton, JP Rollema, H Zorn, SH

Citation: Js. Sprouse et al., Comparison of the novel antipsychotic ziprasidone with clozapine and olanzapine: Inhibition of dorsal raphe cell firing and the role of 5-HT1A receptor activation, NEUROPSYCH, 21(5), 1999, pp. 622-631